Skip to content

Psychoeducation for AlloHCT Caregivers

Cancer | Stem Cell Transplant | Caregivers | Coping | Psychoeduction

Background: Caregivers of patients undergoing allogeneic hematopoietic cell transplantation (alloHCT) for hematological malignancies face significant challenges that can impact their well-being. This study aims to evaluate the feasibility and acceptability of an adapted psychoeducational intervention(PEI) designed to support these caregivers.

Methods: This study will recruit caregivers of alloHCT patients. Participants will be enrolled during pre-transplant clinic visits, typically 2-4 weeks before the scheduled transplant. The intervention consists of eight sessions over 12 weeks, delivered via Microsoft Teams by a nurse facilitator. In the adapted PEI, participants will learn stress management, coping strategies, energy management, goal-setting, communication skills, and support resource access through interactive exercises. Data Collection: Participants will complete questionnaires at three time points: pre-intervention, one month post-transplant, and three months post-transplant. The final assessment will include additional questions about feasibility, acceptability and the initial efficacy of the adapted PEI.

Outcomes: The primary outcomes will be the feasibility and acceptability of the adapted psychoeducational intervention (PEI). Secondary outcomes will include initial efficacy of the adapted PEI on caregiver outcomes such as depression, anxiety, satisfaction with caregiving and quality of life.

Significance: This research aims to assess the feasibility, acceptability and initial efficacy of implementing the adapted PEI for alloHCT caregivers. If found feasible and acceptable, this intervention could potentially improve caregivers' ability to manage caregiving stressors and pave the way for larger-scale randomized studies and implementation.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* Must be caregiver for an adult patient diagnosed with hematological malignancy who is scheduled to receive allogeneic stem cell transplant.
* Are recruited and consented to participate in the caregiver study during the patient's pre-transplant screening phase for allogeneic stem cell transplant.
* Will provide care for the patient from the day of allogeneic stem cell transplant up to 100 days post- transplant.
* Are willing to begin the study intervention no earlier than 0-day post-transplant and not later than 2-weeks post-transplant.

Exclusion Criteria:

* Less than 18 years of age
* Non-English speaking

Study Location

Princess Margaret Cancer Centre, University Health Network
Princess Margaret Cancer Centre, University Health Network
Toronto, Ontario
Canada

Contact Study Team

Backup Contact

Grace Kusi, RN, PhD candidate

[email protected]
Primary Contact

Samantha Mayo, RN, PhD

[email protected]
437-218-0860
Study Sponsored By
University Health Network, Toronto
Participants Required
More Information
Study ID: NCT07116018